PL387217A1 - Borate derivatives of adenosine - Google Patents
Borate derivatives of adenosineInfo
- Publication number
- PL387217A1 PL387217A1 PL387217A PL38721709A PL387217A1 PL 387217 A1 PL387217 A1 PL 387217A1 PL 387217 A PL387217 A PL 387217A PL 38721709 A PL38721709 A PL 38721709A PL 387217 A1 PL387217 A1 PL 387217A1
- Authority
- PL
- Poland
- Prior art keywords
- adenosine
- borate derivatives
- borate
- derivatives
- Prior art date
Links
- OIRDTQYFTABQOQ-KQYNXXCUSA-N Adenosine Natural products C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 title 1
- 229960005305 adenosine Drugs 0.000 title 1
- 150000001642 boronic acid derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
- A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL387217A PL387217A1 (en) | 2009-02-06 | 2009-02-06 | Borate derivatives of adenosine |
| PCT/PL2010/050004 WO2010090541A1 (en) | 2009-02-06 | 2010-02-05 | Borane derivates of adenosine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL387217A PL387217A1 (en) | 2009-02-06 | 2009-02-06 | Borate derivatives of adenosine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL387217A1 true PL387217A1 (en) | 2010-08-16 |
Family
ID=42124263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL387217A PL387217A1 (en) | 2009-02-06 | 2009-02-06 | Borate derivatives of adenosine |
Country Status (2)
| Country | Link |
|---|---|
| PL (1) | PL387217A1 (en) |
| WO (1) | WO2010090541A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170216340A1 (en) * | 2014-08-05 | 2017-08-03 | Instytut Biologii Medycznej Polskiej Akademii Nauk | A Nucleoside Derivative For Use As A Drug, Particularly For The Treatment Of Chronic Lymphocytic Leukemia |
| CN106832242B (en) * | 2017-01-17 | 2018-09-14 | 哈尔滨工业大学无锡新材料研究院 | A kind of polyester synthesis catalyst and preparation method thereof |
| WO2018143403A1 (en) | 2017-02-03 | 2018-08-09 | 国立大学法人東北大学 | Heterocyclic compound |
| CN109503671B (en) * | 2019-01-03 | 2020-12-25 | 曲阜师范大学 | Zwitterionic semi-sandwich iridium complex and preparation method and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6180766B1 (en) | 1993-12-02 | 2001-01-30 | Raymond F. Schinazi | Nucleosides and oligonucleotides containing boron clusters |
| US5599796A (en) | 1993-12-02 | 1997-02-04 | Emory University | Treatment of urogenital cancer with boron neutron capture therapy |
| AU3075800A (en) | 1999-01-22 | 2000-08-07 | Institute Of Medicinal Molecular Design. Inc. | Dicarba-(closo)-dodecaborane derivatives |
| US7084133B2 (en) | 2001-02-09 | 2006-08-01 | Hiroyuki Kagechika | Dicarba-closo-dodecaborane derivatives |
-
2009
- 2009-02-06 PL PL387217A patent/PL387217A1/en not_active Application Discontinuation
-
2010
- 2010-02-05 WO PCT/PL2010/050004 patent/WO2010090541A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010090541A1 (en) | 2010-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201203205B (en) | Benzimidazole-imidazole derivatives | |
| IL217956A0 (en) | N1-sulfonyl-5-fluoropyrimidinone derivatives | |
| IL217953A0 (en) | 5-fluoropyrimidinone derivatives | |
| IL210855A (en) | Adenine derivatives | |
| LT2486039T (en) | Purine derivatives useful as hsp90 inhibitors | |
| IL216007A0 (en) | Isoxazole-pyridine derivatives | |
| IL215109A0 (en) | Isoxazole-pyridazine derivatives | |
| ZA201106855B (en) | Oxasiazole derivatives | |
| IL214941A0 (en) | Isoxazole-pyrazole derivatives | |
| IL217952A0 (en) | N1-acyl-5-fluoropyrimidinone derivatives | |
| ZA201104991B (en) | Deoxyactagardine derivatives | |
| ZA201109370B (en) | Pyrazinooxazepine derivatives | |
| GB0817926D0 (en) | Articles of clothiing | |
| IL218500A0 (en) | Apogossypolone derivatives as anticaner agents | |
| PL387217A1 (en) | Borate derivatives of adenosine | |
| ZA201104279B (en) | Tetrahydronaphthalen-2-ol derivatives | |
| GB0912499D0 (en) | Indopyl-pyridone derivatives | |
| GB0912760D0 (en) | Articles of luggage | |
| GB0821710D0 (en) | Derivatives of dihydroindolone | |
| GB201003234D0 (en) | Saccharide derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |